Global Cardiology Radiopharmaceuticals Market Growth (Status and Outlook) 2026-2032

September 2026 | 114 pages | ID: G3E5270578C6EN
LP Information

Abstracts

The global Cardiology Radiopharmaceuticals market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Cardiology Radiopharmaceuticals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Cardiology Radiopharmaceuticals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Cardiology Radiopharmaceuticals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Cardiology Radiopharmaceuticals players cover GE Healthcare, Cardinal Health, Curium Pharma, Lantheus Medical Imaging, Inc., Eczac?ba?? Monrol Nuclear Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Cardiology Radiopharmaceuticals Industry Forecast” looks at past sales and reviews total world Cardiology Radiopharmaceuticals sales in 2025, providing a comprehensive analysis by region and market sector of projected Cardiology Radiopharmaceuticals sales for 2026 through 2032. With Cardiology Radiopharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiology Radiopharmaceuticals industry.

This Insight Report provides a comprehensive analysis of the global Cardiology Radiopharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cardiology Radiopharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cardiology Radiopharmaceuticals market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiology Radiopharmaceuticals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiology Radiopharmaceuticals.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiology Radiopharmaceuticals market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Technetium-99
• Fluorine-18
• Gallium-67
• Others

Segmentation by Application:

• Therapeutic Use
• Diagnostic Use

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GE Healthcare
• Cardinal Health
• Curium Pharma
• Lantheus Medical Imaging, Inc.
• Eczac?ba?? Monrol Nuclear Products
• Novartis International AG
• Siemens
• China Isotope & Radiation
• Yantai Dongcheng Pharmaceutical
• Jubilant Life Sciences
• Bracco

Contents

1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Cardiology Radiopharmaceuticals Market Size (2021-2032)
  2.1.2 Cardiology Radiopharmaceuticals Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Cardiology Radiopharmaceuticals by Country/Region (2021, 2025 & 2032)
  2.2 Cardiology Radiopharmaceuticals Segment by Type
  2.2.1 Technetium-99
  2.2.2 Fluorine-18
  2.2.3 Gallium-67
  2.2.4 Others
  2.2.5 Cardiology Radiopharmaceuticals Market Size by Type
  2.2.5.1 Cardiology Radiopharmaceuticals Market Size CAGR by Type (2021 VS 2025 VS 2032)
  2.2.5.2 Global Cardiology Radiopharmaceuticals Market Size Market Share by Type (2021-2026)
  2.3 Cardiology Radiopharmaceuticals Segment by Application
  2.3.1 Therapeutic Use
  2.3.2 Diagnostic Use
  2.3.3 Cardiology Radiopharmaceuticals Market Size by Application
  2.3.3.1 Cardiology Radiopharmaceuticals Market Size CAGR by Application (2021 VS 2025 VS 2032)
  2.3.3.2 Global Cardiology Radiopharmaceuticals Market Size Market Share by Application (2021-2026)

3 CARDIOLOGY RADIOPHARMACEUTICALS MARKET SIZE BY PLAYER

  3.1 Cardiology Radiopharmaceuticals Market Size Market Share by Player
  3.1.1 Global Cardiology Radiopharmaceuticals Revenue by Player (2021-2026)
  3.1.2 Global Cardiology Radiopharmaceuticals Revenue Market Share by Player (2021-2026)
  3.2 Global Cardiology Radiopharmaceuticals Key Players Head office and Products Offered
  3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.4 New Products and Potential Entrants
  3.5 Mergers & Acquisitions, Expansion

4 CARDIOLOGY RADIOPHARMACEUTICALS BY REGION

  4.1 Cardiology Radiopharmaceuticals Market Size by Region (2021-2026)
  4.2 Global Cardiology Radiopharmaceuticals Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Cardiology Radiopharmaceuticals Market Size Growth (2021-2026)
  4.4 APAC Cardiology Radiopharmaceuticals Market Size Growth (2021-2026)
  4.5 Europe Cardiology Radiopharmaceuticals Market Size Growth (2021-2026)
  4.6 Middle East & Africa Cardiology Radiopharmaceuticals Market Size Growth (2021-2026)

5 AMERICAS

  5.1 Americas Cardiology Radiopharmaceuticals Market Size by Country (2021-2026)
  5.2 Americas Cardiology Radiopharmaceuticals Market Size by Type (2021-2026)
  5.3 Americas Cardiology Radiopharmaceuticals Market Size by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Cardiology Radiopharmaceuticals Market Size by Region (2021-2026)
  6.2 APAC Cardiology Radiopharmaceuticals Market Size by Type (2021-2026)
  6.3 APAC Cardiology Radiopharmaceuticals Market Size by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia

7 EUROPE

  7.1 Europe Cardiology Radiopharmaceuticals Market Size by Country (2021-2026)
  7.2 Europe Cardiology Radiopharmaceuticals Market Size by Type (2021-2026)
  7.3 Europe Cardiology Radiopharmaceuticals Market Size by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Cardiology Radiopharmaceuticals by Region (2021-2026)
  8.2 Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Type (2021-2026)
  8.3 Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 GLOBAL CARDIOLOGY RADIOPHARMACEUTICALS MARKET FORECAST

  10.1 Global Cardiology Radiopharmaceuticals Forecast by Region (2027-2032)
  10.1.1 Global Cardiology Radiopharmaceuticals Forecast by Region (2027-2032)
  10.1.2 Americas Cardiology Radiopharmaceuticals Forecast
  10.1.3 APAC Cardiology Radiopharmaceuticals Forecast
  10.1.4 Europe Cardiology Radiopharmaceuticals Forecast
  10.1.5 Middle East & Africa Cardiology Radiopharmaceuticals Forecast
  10.2 Americas Cardiology Radiopharmaceuticals Forecast by Country (2027-2032)
  10.2.1 United States Market Cardiology Radiopharmaceuticals Forecast
  10.2.2 Canada Market Cardiology Radiopharmaceuticals Forecast
  10.2.3 Mexico Market Cardiology Radiopharmaceuticals Forecast
  10.2.4 Brazil Market Cardiology Radiopharmaceuticals Forecast
  10.3 APAC Cardiology Radiopharmaceuticals Forecast by Region (2027-2032)
  10.3.1 China Cardiology Radiopharmaceuticals Market Forecast
  10.3.2 Japan Market Cardiology Radiopharmaceuticals Forecast
  10.3.3 Korea Market Cardiology Radiopharmaceuticals Forecast
  10.3.4 Southeast Asia Market Cardiology Radiopharmaceuticals Forecast
  10.3.5 India Market Cardiology Radiopharmaceuticals Forecast
  10.3.6 Australia Market Cardiology Radiopharmaceuticals Forecast
  10.4 Europe Cardiology Radiopharmaceuticals Forecast by Country (2027-2032)
  10.4.1 Germany Market Cardiology Radiopharmaceuticals Forecast
  10.4.2 France Market Cardiology Radiopharmaceuticals Forecast
  10.4.3 UK Market Cardiology Radiopharmaceuticals Forecast
  10.4.4 Italy Market Cardiology Radiopharmaceuticals Forecast
  10.4.5 Russia Market Cardiology Radiopharmaceuticals Forecast
  10.5 Middle East & Africa Cardiology Radiopharmaceuticals Forecast by Region (2027-2032)
  10.5.1 Egypt Market Cardiology Radiopharmaceuticals Forecast
  10.5.2 South Africa Market Cardiology Radiopharmaceuticals Forecast
  10.5.3 Israel Market Cardiology Radiopharmaceuticals Forecast
  10.5.4 Turkey Market Cardiology Radiopharmaceuticals Forecast
  10.6 Global Cardiology Radiopharmaceuticals Forecast by Type (2027-2032)
  10.7 Global Cardiology Radiopharmaceuticals Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Cardiology Radiopharmaceuticals Forecast

11 KEY PLAYERS ANALYSIS

  11.1 GE Healthcare
  11.1.1 GE Healthcare Company Information
  11.1.2 GE Healthcare Cardiology Radiopharmaceuticals Product Offered
  11.1.3 GE Healthcare Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 GE Healthcare Main Business Overview
  11.1.5 GE Healthcare Latest Developments
  11.2 Cardinal Health
  11.2.1 Cardinal Health Company Information
  11.2.2 Cardinal Health Cardiology Radiopharmaceuticals Product Offered
  11.2.3 Cardinal Health Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Cardinal Health Main Business Overview
  11.2.5 Cardinal Health Latest Developments
  11.3 Curium Pharma
  11.3.1 Curium Pharma Company Information
  11.3.2 Curium Pharma Cardiology Radiopharmaceuticals Product Offered
  11.3.3 Curium Pharma Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Curium Pharma Main Business Overview
  11.3.5 Curium Pharma Latest Developments
  11.4 Lantheus Medical Imaging, Inc.
  11.4.1 Lantheus Medical Imaging, Inc. Company Information
  11.4.2 Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Product Offered
  11.4.3 Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Lantheus Medical Imaging, Inc. Main Business Overview
  11.4.5 Lantheus Medical Imaging, Inc. Latest Developments
  11.5 Eczac?ba?? Monrol Nuclear Products
  11.5.1 Eczac?ba?? Monrol Nuclear Products Company Information
  11.5.2 Eczac?ba?? Monrol Nuclear Products Cardiology Radiopharmaceuticals Product Offered
  11.5.3 Eczac?ba?? Monrol Nuclear Products Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Eczac?ba?? Monrol Nuclear Products Main Business Overview
  11.5.5 Eczac?ba?? Monrol Nuclear Products Latest Developments
  11.6 Novartis International AG
  11.6.1 Novartis International AG Company Information
  11.6.2 Novartis International AG Cardiology Radiopharmaceuticals Product Offered
  11.6.3 Novartis International AG Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Novartis International AG Main Business Overview
  11.6.5 Novartis International AG Latest Developments
  11.7 Siemens
  11.7.1 Siemens Company Information
  11.7.2 Siemens Cardiology Radiopharmaceuticals Product Offered
  11.7.3 Siemens Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Siemens Main Business Overview
  11.7.5 Siemens Latest Developments
  11.8 China Isotope & Radiation
  11.8.1 China Isotope & Radiation Company Information
  11.8.2 China Isotope & Radiation Cardiology Radiopharmaceuticals Product Offered
  11.8.3 China Isotope & Radiation Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 China Isotope & Radiation Main Business Overview
  11.8.5 China Isotope & Radiation Latest Developments
  11.9 Yantai Dongcheng Pharmaceutical
  11.9.1 Yantai Dongcheng Pharmaceutical Company Information
  11.9.2 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product Offered
  11.9.3 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Yantai Dongcheng Pharmaceutical Main Business Overview
  11.9.5 Yantai Dongcheng Pharmaceutical Latest Developments
  11.10 Jubilant Life Sciences
  11.10.1 Jubilant Life Sciences Company Information
  11.10.2 Jubilant Life Sciences Cardiology Radiopharmaceuticals Product Offered
  11.10.3 Jubilant Life Sciences Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Jubilant Life Sciences Main Business Overview
  11.10.5 Jubilant Life Sciences Latest Developments
  11.11 Bracco
  11.11.1 Bracco Company Information
  11.11.2 Bracco Cardiology Radiopharmaceuticals Product Offered
  11.11.3 Bracco Cardiology Radiopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Bracco Main Business Overview
  11.11.5 Bracco Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cardiology Radiopharmaceuticals Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cardiology Radiopharmaceuticals Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Technetium-99
Table 4. Major Players of Fluorine-18
Table 5. Major Players of Gallium-67
Table 6. Major Players of Others
Table 7. Cardiology Radiopharmaceuticals Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Cardiology Radiopharmaceuticals Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Cardiology Radiopharmaceuticals Market Size Market Share by Type (2021-2026)
Table 10. Cardiology Radiopharmaceuticals Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Cardiology Radiopharmaceuticals Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Cardiology Radiopharmaceuticals Market Size Market Share by Application (2021-2026)
Table 13. Global Cardiology Radiopharmaceuticals Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Cardiology Radiopharmaceuticals Revenue Market Share by Player (2021-2026)
Table 15. Cardiology Radiopharmaceuticals Key Players Head office and Products Offered
Table 16. Cardiology Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Cardiology Radiopharmaceuticals Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Cardiology Radiopharmaceuticals Market Size Market Share by Region (2021-2026)
Table 21. Global Cardiology Radiopharmaceuticals Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Cardiology Radiopharmaceuticals Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Cardiology Radiopharmaceuticals Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Cardiology Radiopharmaceuticals Market Size Market Share by Country (2021-2026)
Table 25. Americas Cardiology Radiopharmaceuticals Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Cardiology Radiopharmaceuticals Market Size Market Share by Type (2021-2026)
Table 27. Americas Cardiology Radiopharmaceuticals Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Cardiology Radiopharmaceuticals Market Size Market Share by Application (2021-2026)
Table 29. APAC Cardiology Radiopharmaceuticals Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Cardiology Radiopharmaceuticals Market Size Market Share by Region (2021-2026)
Table 31. APAC Cardiology Radiopharmaceuticals Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Cardiology Radiopharmaceuticals Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Cardiology Radiopharmaceuticals Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Cardiology Radiopharmaceuticals Market Size Market Share by Country (2021-2026)
Table 35. Europe Cardiology Radiopharmaceuticals Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Cardiology Radiopharmaceuticals Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Cardiology Radiopharmaceuticals
Table 41. Key Market Challenges & Risks of Cardiology Radiopharmaceuticals
Table 42. Key Industry Trends of Cardiology Radiopharmaceuticals
Table 43. Global Cardiology Radiopharmaceuticals Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Cardiology Radiopharmaceuticals Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Cardiology Radiopharmaceuticals Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Cardiology Radiopharmaceuticals Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. GE Healthcare Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 48. GE Healthcare Cardiology Radiopharmaceuticals Product Offered
Table 49. GE Healthcare Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. GE Healthcare Main Business
Table 51. GE Healthcare Latest Developments
Table 52. Cardinal Health Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 53. Cardinal Health Cardiology Radiopharmaceuticals Product Offered
Table 54. Cardinal Health Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Cardinal Health Main Business
Table 56. Cardinal Health Latest Developments
Table 57. Curium Pharma Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 58. Curium Pharma Cardiology Radiopharmaceuticals Product Offered
Table 59. Curium Pharma Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Curium Pharma Main Business
Table 61. Curium Pharma Latest Developments
Table 62. Lantheus Medical Imaging, Inc. Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 63. Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Product Offered
Table 64. Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Lantheus Medical Imaging, Inc. Main Business
Table 66. Lantheus Medical Imaging, Inc. Latest Developments
Table 67. Eczac?ba?? Monrol Nuclear Products Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 68. Eczac?ba?? Monrol Nuclear Products Cardiology Radiopharmaceuticals Product Offered
Table 69. Eczac?ba?? Monrol Nuclear Products Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Eczac?ba?? Monrol Nuclear Products Main Business
Table 71. Eczac?ba?? Monrol Nuclear Products Latest Developments
Table 72. Novartis International AG Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 73. Novartis International AG Cardiology Radiopharmaceuticals Product Offered
Table 74. Novartis International AG Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Novartis International AG Main Business
Table 76. Novartis International AG Latest Developments
Table 77. Siemens Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 78. Siemens Cardiology Radiopharmaceuticals Product Offered
Table 79. Siemens Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Siemens Main Business
Table 81. Siemens Latest Developments
Table 82. China Isotope & Radiation Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 83. China Isotope & Radiation Cardiology Radiopharmaceuticals Product Offered
Table 84. China Isotope & Radiation Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. China Isotope & Radiation Main Business
Table 86. China Isotope & Radiation Latest Developments
Table 87. Yantai Dongcheng Pharmaceutical Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 88. Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product Offered
Table 89. Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Yantai Dongcheng Pharmaceutical Main Business
Table 91. Yantai Dongcheng Pharmaceutical Latest Developments
Table 92. Jubilant Life Sciences Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 93. Jubilant Life Sciences Cardiology Radiopharmaceuticals Product Offered
Table 94. Jubilant Life Sciences Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Jubilant Life Sciences Main Business
Table 96. Jubilant Life Sciences Latest Developments
Table 97. Bracco Details, Company Type, Cardiology Radiopharmaceuticals Area Served and Its Competitors
Table 98. Bracco Cardiology Radiopharmaceuticals Product Offered
Table 99. Bracco Cardiology Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Bracco Main Business
Table 101. Bracco Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Cardiology Radiopharmaceuticals Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cardiology Radiopharmaceuticals Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cardiology Radiopharmaceuticals Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cardiology Radiopharmaceuticals Sales Market Share by Country/Region (2025)
Figure 8. Cardiology Radiopharmaceuticals Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cardiology Radiopharmaceuticals Market Size Market Share by Type in 2025
Figure 10. Cardiology Radiopharmaceuticals in Therapeutic Use
Figure 11. Global Cardiology Radiopharmaceuticals Market: Therapeutic Use (2021-2026) & ($ millions)
Figure 12. Cardiology Radiopharmaceuticals in Diagnostic Use
Figure 13. Global Cardiology Radiopharmaceuticals Market: Diagnostic Use (2021-2026) & ($ millions)
Figure 14. Global Cardiology Radiopharmaceuticals Market Size Market Share by Application in 2025
Figure 15. Global Cardiology Radiopharmaceuticals Revenue Market Share by Player in 2025
Figure 16. Global Cardiology Radiopharmaceuticals Market Size Market Share by Region (2021-2026)
Figure 17. Americas Cardiology Radiopharmaceuticals Market Size 2021-2026 ($ millions)
Figure 18. APAC Cardiology Radiopharmaceuticals Market Size 2021-2026 ($ millions)
Figure 19. Europe Cardiology Radiopharmaceuticals Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Cardiology Radiopharmaceuticals Market Size 2021-2026 ($ millions)
Figure 21. Americas Cardiology Radiopharmaceuticals Value Market Share by Country in 2025
Figure 22. United States Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Cardiology Radiopharmaceuticals Market Size Market Share by Region in 2025
Figure 27. APAC Cardiology Radiopharmaceuticals Market Size Market Share by Type (2021-2026)
Figure 28. APAC Cardiology Radiopharmaceuticals Market Size Market Share by Application (2021-2026)
Figure 29. China Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 33. India Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Cardiology Radiopharmaceuticals Market Size Market Share by Country in 2025
Figure 36. Europe Cardiology Radiopharmaceuticals Market Size Market Share by Type (2021-2026)
Figure 37. Europe Cardiology Radiopharmaceuticals Market Size Market Share by Application (2021-2026)
Figure 38. Germany Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 39. France Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Cardiology Radiopharmaceuticals Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Cardiology Radiopharmaceuticals Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Cardiology Radiopharmaceuticals Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Cardiology Radiopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 52. APAC Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 53. Europe Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 55. United States Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 56. Canada Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 57. Mexico Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 58. Brazil Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 59. China Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 60. Japan Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 61. Korea Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 63. India Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 64. Australia Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 65. Germany Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 66. France Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 67. UK Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 68. Italy Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 69. Russia Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 70. Egypt Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 71. South Africa Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 72. Israel Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 73. Turkey Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 74. Global Cardiology Radiopharmaceuticals Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Cardiology Radiopharmaceuticals Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Cardiology Radiopharmaceuticals Market Size 2027-2032 ($ millions)